Oral cancers are among the common head and neck malignancies. Different anticancer
therapy modalities such as chemotherapy, immunotherapy, radiation therapy, and also …

Metastasis and failure of present-day therapies represent the most common causes of
mortality in patients with cutaneous melanoma. To identify the underlying genetic and …

Preoperative immunotherapy for head and neck cancers: state... : Current Opinion in Oncology
Preoperative immunotherapy for head and neck cancers: state of art : Current Opinion in Oncology …

Oral cavity squamous cell carcinoma (OCSCC) is a prevalent surgically treated subset of
head and neck cancer with frequent recurrence and poor survival. Immunotherapy has …

Background Loss-of-function of PD-L1 induces therapy resistance of anti-PD-1/L1 therapy,
and the complex regulatory mechanisms are not completely understood. We previously …

About 50% of patients with locally advanced head and neck squamous cell carcinoma
(HNSCC) experience recurrences after definitive therapy. The presurgical administration of …

Background This study aimed to identify potential biomarkers in patients with recurrent or
metastatic head and neck squamous cell carcinoma (HNSCC) and further probe the …

An active host adaptive response is characterized by the existence of programmed cell
death protein 1 (PD‐1)+/IFN‐γ+ cytotoxic T cells and IFN‐γ‐induced PD‐L1+ tumor cells …

Background Prostate cancer (PCA) is the fifth leading cause of cancer-related deaths
worldwide, with limited treatment options in the advanced stages. The immunosuppressive …

Advanced head and neck cancer (HNC) is functionally and aesthetically destructive, and
despite significant advances in therapy, overall survival is poor, financial toxicity is high, and …